Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Second pivotal phase III trial of lubiprostone in paediatric patients with functional constipation.

Next Previous
X
Search
Trial Profile

Second pivotal phase III trial of lubiprostone in paediatric patients with functional constipation.

Status: Planning
Phase of Trial: Phase III

Latest Information Update: 17 Mar 2014

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lubiprostone (Primary)
  • Indications Constipation
  • Focus Registrational; Therapeutic Use

    • Most Recent Events

    • 14 Mar 2014 Initiation of this trial may be affected following findings from an adult chronic idiopathic constipation trial that evaluated the same liquid formulation of lubiprostone as the one to be used in this trial. Safety was not an issue.
    • 24 Nov 2013 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top